RegWardenFDA facility compliance records
Recall

Class II — Mevion Medical Systems, Inc.

Recalling firmMevion Medical Systems, Inc.
Registered facilityMEVION MEDICAL SYSTEMS, INC. (the firm's only registered facility)
ClassificationClass II
StatusTerminated
ReasonQFix has advised Mevion Medical Systems that they are identifying unauthorized combinations of QFix Couch Tops with non-QFix devices in clinical use. The kVue Oen Touch latch consists of a precision latch mechanism that can be damaged when used with incompatible (third-party) accessories. This can create unsafe conditions for use and may compromise the subsequent use of any kVue inserts, whether authorized or not. Use of unauthorized or unvalidated inserts may lead to an incorrect patient treatment or physical injury.
ProductMEVION S250/MEVION S250i Proton Beam Radiation therapy system Product Usage: Indicated for the delivery of radiation for the treatment of patients with localized tumors or other conditions susceptible to treatment by radiation.
Quantity7
DistributionUS Nationwide Distribution in the states of DC, FL, MO, NJ, OH, and OK.
Initiated2018-06-29
Classified2018-08-10
Terminated2018-10-02
Recall numberZ-2746-2018
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Mevion Medical Systems, Inc. (Z-2746-2018).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/80615/

Not open yet

Alerts for Mevion Medical Systems, Inc.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.